Densitas® and ScreenPoint Medical Set to Improve Patient Outcomes

HALIFAX, NS, June 7, 2023 /PRNewswire/ — Densitas® Inc., a global provider of A.I. solutions for digital mammography and breast screening, today announced a strategic partnership with ScreenPoint Medical, a developer of innovative breast imaging solutions. The companies will work together to increase the reach of their industry-leading AI solutions, transforming the delivery of care … Read more

Společnost iHerb navázala spolupráci se společností CJ Logistics s cílem posílení dostupnosti produktů pro zdraví a wellness na Blízkém východě a v Africe English

Společnost iHerb uspořádala v Rijádu společnou slavnostní akci, na které oznámila vznik nového partnerství za účelem vybudování prvního centra pro elektronický obchod v Saúdské Arábii  IRVINE, Kalifornie, 7. června 2023 /PRNewswire/ – Společnost iHerb, celosvětový lídr v oblasti zdraví a wellness, s potěšením oznamuje navázání partnerství se společností CJ Logistics, lídrem v oblasti logistických řešení, … Read more

Crunch Fitness Evansville Providing Jobs, Benefiting Neighboring Businesses and Boosting Local Economy

EVANSVILLE, Ind., June 7, 2023 /PRNewswire/ — One of the fastest growing Crunch franchisees, Fitness Ventures LLC, opened its newest location, Crunch Evansville on April 28, 2023. A $5 million, 35,000-square-foot fitness facility, with $1 million dollars worth of state-of-the-art equipment. Crunch is located at 306 N Green River Rd, Evansville, IN. Opening month has … Read more

Royal Health Launches Artificial Intelligence Unit Aimed at Operational Decisions

NEW YORK, June 7, 2023 /PRNewswire/ — Royal Health Inc., a leading provider of healthcare software and services, is pleased to announce the establishment of its new subsidiary, RoyalAi Inc. This innovative unit specializes in harnessing the power of artificial intelligence (AI) to enhance operational decision-making processes within the radiology and adjacent markets. RoyalAi has … Read more

Mark Cuban Cost Plus Drug Company and HealthDyne Announce Pharmacy Partnership

HealthDyne partners with Cost Plus Drugs to further lower costs and expand access to affordable prescription medications for those living with chronic diseases. LAKELAND, Fla., June 7, 2023 /PRNewswire/ — Ongoing changes in the healthcare industry have fueled innovators to reinvent the future, forge new paths, make smart decisions, and find aligned partners to disrupt … Read more

CloudFabrix Launches and Demonstrates Observability Data Modernization and Composable Dashboard Services on Cisco’s Full-Stack Observability Platform at Cisco Live 23

CloudFabrix showcases the Power and Extensibility of the Cisco FSO Platform, with Data Modernization, and Composable Dashboards for Applications Telemetry LAS VEGAS, June 7, 2023 /PRNewswire/ — Today at Cisco Live, Cisco’s annual IT and communications conference, CloudFabrix, the inventor of Robotic Data Automation Fabric (RDAF) and the “Data-centric AIOps” leader announced the launch of Observability Data … Read more

Rigel Announces Presentation of Data from Analysis of REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML

Durable remissions observed in patients relapsed or refractory to prior venetoclax-based regimens Data featured in a poster presentation at the European Hematology Association (EHA) 2023 Hybrid Congress SOUTH SAN FRANCISCO, Calif., June 7, 2023 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced promising data from an analysis of the Phase 2 study evaluating REZLIDHIA® … Read more

Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases

Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic, PhD, Director AbbVie Ventures, to join Mozart’s Board of Directors SEATTLE, June 7, 2023 /PRNewswire/ — Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases, today announced … Read more

Samyang assina acordo de parceria com Yxintent, China, para enchimento dérmico Lafullen®

A Yxintent venderá exclusivamente o Lafullen® após realizar estudos clínicos e receber aprovação na China, com a Samyang fornecendo produtos no valor de KRW 100 bilhões nos próximos cinco anos  Enchimento dérmico biodegradável de longa duração com volume natural e efeitos duradouros, segurança e eficácia comprovadas Obteve aprovação na Indonésia em abril, expandindo para o mercado … Read more

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAMILTON, ON and BOSTON, June 7, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 68,000 shares of its common stock to two … Read more